Sysmex's haematology analyser:
This article was originally published in Clinica
Executive Summary
The XE-5000 automated haematology analyser developed by Sysmex America has been granted 510(k) approval by the US FDA. It uses Sysmex's fluorescent flow cytometry technology to provide both routine haematology testing and abnormal cell flagging within a single sample run. The XE-5000 can be remotely monitored by Sysmex technicians, who can help correct any issues prior to system or part failures. The device will be on sale in the US, Latin America and in Canada within the month and is aimed at hospital or university laboratories and clinics with renal, oncology and acute care patient populations. Sysmex America, of Mundelein, Illinois, is the US headquarters of Kobe, Japan-based Sysmex.